Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.859 |
High Similarity |
NPD37 |
Approved |
0.8553 |
High Similarity |
NPD6234 |
Discontinued |
0.8544 |
High Similarity |
NPD4967 |
Phase 2 |
0.8544 |
High Similarity |
NPD4966 |
Approved |
0.8544 |
High Similarity |
NPD4965 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8303 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8232 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8107 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7987 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7925 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7816 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7806 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7758 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7707 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7636 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7633 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD7054 |
Approved |
0.759 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7572 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7557 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7532 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7486 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.747 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7446 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.744 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7434 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.743 |
Intermediate Similarity |
NPD6842 |
Approved |
0.743 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7419 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7412 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7403 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7372 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7358 |
Intermediate Similarity |
NPD5762 |
Approved |
0.733 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7321 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7312 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7287 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7257 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7256 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7256 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7247 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7225 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7219 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7213 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7178 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7171 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD919 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7119 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7117 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7111 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7111 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7105 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7088 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7076 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7076 |
Intermediate Similarity |
NPD5402 |
Approved |
0.707 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7067 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7067 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7047 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7039 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7039 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD7296 |
Approved |
0.702 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.701 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7 |
Intermediate Similarity |
NPD5089 |
Approved |
0.6994 |
Remote Similarity |
NPD3749 |
Approved |
0.6989 |
Remote Similarity |
NPD5242 |
Approved |
0.6988 |
Remote Similarity |
NPD1511 |
Approved |
0.6987 |
Remote Similarity |
NPD2861 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6982 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6975 |
Remote Similarity |
NPD6099 |
Approved |
0.6975 |
Remote Similarity |
NPD6100 |
Approved |
0.6971 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6964 |
Remote Similarity |
NPD5403 |
Approved |
0.6963 |
Remote Similarity |
NPD5006 |
Approved |
0.6963 |
Remote Similarity |
NPD5005 |
Approved |
0.6962 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6951 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD4749 |
Approved |
0.6946 |
Remote Similarity |
NPD5401 |
Approved |
0.6946 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD1933 |
Approved |
0.6928 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6909 |
Remote Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD1512 |
Approved |
0.6903 |
Remote Similarity |
NPD1283 |
Approved |
0.6901 |
Remote Similarity |
NPD7411 |
Suspended |
0.6901 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6894 |
Remote Similarity |
NPD6653 |
Approved |
0.689 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6882 |
Remote Similarity |
NPD4005 |
Discontinued |
0.6882 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD4140 |
Approved |
0.6875 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6875 |
Remote Similarity |
NPD1247 |
Approved |
0.6871 |
Remote Similarity |
NPD2796 |
Approved |
0.6867 |
Remote Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD2797 |
Approved |
0.6855 |
Remote Similarity |
NPD3764 |
Approved |
0.6842 |
Remote Similarity |
NPD4420 |
Approved |
0.6839 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6832 |
Remote Similarity |
NPD447 |
Suspended |
0.6829 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6829 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6813 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.681 |
Remote Similarity |
NPD7033 |
Discontinued |
0.681 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.681 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6807 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6807 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6805 |
Remote Similarity |
NPD6273 |
Approved |
0.6802 |
Remote Similarity |
NPD6386 |
Approved |
0.6802 |
Remote Similarity |
NPD6385 |
Approved |
0.68 |
Remote Similarity |
NPD4055 |
Discovery |
0.6797 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6797 |
Remote Similarity |
NPD5126 |
Approved |
0.6788 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6776 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6774 |
Remote Similarity |
NPD1608 |
Approved |
0.677 |
Remote Similarity |
NPD1240 |
Approved |
0.6768 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6768 |
Remote Similarity |
NPD6032 |
Approved |
0.6768 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6766 |
Remote Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD920 |
Approved |
0.676 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD3496 |
Discontinued |
0.675 |
Remote Similarity |
NPD7985 |
Registered |
0.675 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.675
|
Remote Similarity |
NPD7930 |
Approved |